AKT1 and glioblastoma: Numerous studies have shown that the frequency of gene mutations and copy number amplification of various regulators in the receptor tyrosine kinase (RTK)/AKT pathway, which is an important regulatory pathway closely related to the pathogenesis and progression of GBM, in glioblastoma is 88% (35, 36).